Bushu Pharmaceuticals
Celebrating 25 years as Japan's premier CDMO, Bushu Pharmaceuticals is a dedicated contract manufactuer of pharmaceutical products and clinical trial materials.
See below for the Latest Bushu Pharmaceuticals News, Analysis, Profit Results, Share Price Information, and Commentary.
Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Bushu Pharmaceuticals' ESG Promotion Manager, Yasuko Watanabe, discusses the company's commitment to sustainability in healthcare, including CO2 reduction initiatives and wastewater treatment upgrades.
2 days ago
Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Bushu Pharmaceuticals' ESG Promotion Manager, Yasuko Watanabe, discusses the company's commitment to sustainability in healthcare, including CO2 reduction initiatives and wastewater treatment upgrades.
2 days ago
Bushu Pharmaceuticals brings home two wins at Healthcare Asia Pharma Awards 2024
It has initiated CO2 emission reduction and wastewater management initiatives to support the environment and the industry.
Most Read
1. India spurs healthcare digitalisation with Ayushman Bharat Digital Mission 2. IHH invests in Belun Technology for AI-powered sleep diagnostic technology 3. Malaysia’s medical device market to reach $3.6b by 2028 4. Medical spa market eyes growth driven by customer loyalty 5. IHH Healthcare Malaysia initiative drives solar power use across its networkResource Center
Read Here
Advertise
Sign Up
Event News
Event News
Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
![Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals]()
Bushu Pharmaceuticals' ESG Promotion Manager, Yasuko Watanabe, discusses the company's commitment to sustainability in healthcare, including CO2 reduction initiatives and wastewater treatment upgrades.
Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Bushu Pharmaceuticals' ESG Promotion Manager, Yasuko Watanabe, discusses the company's commitment to sustainability in healthcare, including CO2 reduction initiatives and wastewater treatment upgrades.
Commentary
Evolving the Healthcare landscape in Singapore with Integrated Ambulatory Surgical Centres